People Living With Cancer

Published Works: Miscellaneous Tumors

Adamantinoma
Adamantinoma is an uncommon primary bone neoplasm with a strong predilection for the tibia. Recent studies have confirmed the epithelial nature of this tumor. Adamantinomas present most frequently during early adulthood as painful leg masses with variable symptom duration, ranging from a few months to a few years. These tumors appear in the tibial diaphysis as a well-circumscribed, eccentric, lytic, sometimes multicystic lesion with surrounding sclerosis. The long bone is often expanded and the cortex may or may not be intact, but there is no periosteal reaction. The lesional tissue is grossly gray-white in color and rubbery-firm in consistency, and cystic regions containing blood or straw-colored fluid may be present. Adamantinomas have a wide variety of histologic appearances. Most frequently, the tumor has a basaloid pattern, composed of groups of cells which peripherally have palisading epithelial cells. Other histologic patterns are tubular, spindle, and squamoid. Between these islands of epithelial cells is a hypocellular, poorly organized, fibrous connective tissue, which often contains areas resembling osteofibrous dysplasia. The tubular pattern may be confused histologically with a vascular tumor. Immunohistochemical studies of adamantionma demonstrate the presence of cytokeratin in the tumor cells, and absence of endothelial markers. At the electron microscope level, the cells show epithelial features. The treatment of adamantinoma is en bloc excision with amputation reserved for large, unresectable, or recurrent lesions. This tumor has been reported to metastasize to the lungs in approximately 20 to 25 percent of cases.

There is recent evidence in the literature that there is a new type of adamantinoma called osteofibrous dysplasia-like or "differentiated" adamantinoma. It is more common among younger patients, contains a prominent osteofibrous dysplasia-like tissue, and has a good prognosis following curettage alone.

Chordoma
A chordoma is a rare tumor arising from remnants of the primitive notochord. It is a solitary lesion found in the midline at either end of the spine, most commonly first at the sacrococcygeal region (50 to 60 percent) and second at the sphenooccipital region. Other sites of the spine are less frequently involved. Chordomas have a predilection for middle-aged males and present with pain of gradual onset and of long duration. There may be a large presacral rectal mass that is palpable on rectal examination, and the patient may present with bowel or bladder dysfunction from compression of the sacral roots. Chordomas of the sphenoid or cervical spine may present with a cranial nerve palsy or nasopharyngeal mass. Radiographically, the tumor is destructive and associated with an expansile soft tissue mass. MRI or CT scan may help to delineate the extent of the tumor. On gross inspection the tumor appears gray, lobulated, gelatinous, and encased in a pseudocapsule. Histologically, the cells are polyhedral in shape and often have eosinophilic cytoplasm and numerous vacuoles which displace the nucleus (physaliphorous cells). The tissue has a lobular architecture and the cells are disposed in cords, trabeculae, or sheets, which are separated by abundant mucoid and myxoid matrix. Immunohistochemically, chordoma cells show positive reaction to S-100 protein, cytokeratin, and epithelial membrane antigen. These studies help to distinguish chordoma from other malignant tumors such as myxoid chondrosarcomas and metastatic adenocarcinomas.

Wide local resection is the recommended treatment; however, because the patients often present late in the clinical course and because of its close proximity to neurologic structures, the tumor is usually not resectable. Radiation is indicated. These tumors have a very high rate of recurrence even with surgical treatment. Metastases develop rather frequently to the lungs, liver, and other tissues.

A small percentage of chordomas of the sphenooccipital region have a prominent chondroid component and are designated as chondroid chordomas. They apparently have a better prognosis than conventional chordomas. Rarely, chordomas may have a high-grade sarcomatous component adjacent to it, usually resembling malignant fibrous histiocytoma. These tumors are called dedifferentiated chordomas and have a bad prognosis.

Lipoma
Lipomas primary in bone are rare. They occur in adults and predilect the femur, fibula, tibia, and calcaneous. Radiographs demonstrate a lytic lesion with well-defined margins. Central areas of radiodensity may be seen. MRI is helpful in the diagnosis of lipoma, showing high signal intensity in both T1- and T2-weighted images. Histologically, there is mature adipose tissue with atrophic bone trabeculae. Fat necrosis and calcification also may be seen. Treatment is by curettage. Liposarcoma is exceedingly rare.

Leiomyosarcoma
Leiomyosarcoma is a rare tumor affecting adults and most commonly predilecting the femur and tibia. Radiographs show nonspecific lytic changes of a malignant nature. Histologically, there are spindle cells with acidophilic cytoplasm, and the nuclei show varying degrees of atypia and mitotic activity. There is a dense fascicular pattern. Immunohistochemical reactivity to muscle markers are important findings in order to differentiate this tumor from malignant fibrous histiocytoma and fibrosarcoma. En bloc resection or amputation is recommended. At least 50 percent of patients die of metastases. Primary leiomyosarcoma of bone should be distinguished clinically from metastatic leiomyosarcoma to bone, particularly from the uterus.

Schwannoma
Intraosseous schwannoma (neurilemmoma) is rare and arises from the sacrum, mandible, and other bones. Radiographically, it is a lytic lesion, and microscopically, it shows the typical features of Antoni A and B tissue as seen in the soft tissue counterpart. In most cases of neurofibroma with bone involvement, the tumors are located in the soft tissue with secondary extension into bone.

Previous Page



Copyright © 2010 Musculo-Skeletal Tumor Orthopaedic Practice | Disclaimer
Last Modified: July 30, 2003